Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients

Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients

To evaluate the prevalence of SARS-CoV-2 genome in patients with asymptomatic and moderately symptomatic COVID19.

Patients attending to the COVID19 screening facility of Paris South University hospital and willing to participate to the study will have both nasopharyngeal and conjunctival swab for SARS-CV-2 genome detection using PCR. The project will evaluate the prevalence of positive conjunctival swabs in patients with positive nasopharyngeal swab. These results will be corelated to symptoms of disease assessed with a standardized questionnaire.

Inclusion Criteria:

• Patients receiving diagnostic nasopharyngeal PCR for COVID-19 as part of the usual care
• Age ≥ 18.
• Information and signature of consent
• Affiliated with a social security scheme or entitled

Exclusion Criteria:

• Refusal to participate in the study
• Eye surgery less than 3 months old
• Unable to give informed consent
• No coverage through the health insurance system
• Patient under judicial protection
• Patient on AME